Global longitudinal strain is a better metric than left ventricular ejection fraction: lessons learned from cancer therapeutic-related cardiac dysfunction.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This review aims to highlight the utility of global longitudinal strain (GLS) in cancer therapeutic-related cardiac dysfunction (CTRCD), with an attempt to stipulate that GLS might be a better measure than left ventricular ejection fraction (LVEF).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Curr Opin Cardiol

Title: Current opinion in cardiology

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1531-7080

ISSN (Print): 0268-4705

Publication date (Electronic): March 2020

Volume: 35

Issue: 2

Affiliations

[1 ] Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Clinical Cardiology and Cardiovascular Imaging, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Article

Publisher Item ID: 00001573-202003000-00014

DOI: 10.1097/HCO.0000000000000716

PubMed ID: 31850935

SO-VID: 459a739f-5802-4d5a-93c1-e33610ae96b2

History

Data availability:

Comments

Comment on this article

scite_

Cited by 8

See all cited by